1. St. Jude Medical's CEO Discusses Q2 2011 Results - Earnings Call Transcript

    St. Jude Medical's CEO Discusses Q2 2011 Results - Earnings Call Transcript
    St. Jude Medical's CEO Discusses Q2 2011 Results - Earnings Call TranscriptSeeking AlphaThe most important new growth drivers in our Vascular business in the near term are our fractional flow reserve or FFR product lines and our Optical Coherence Tomography or OCT product lines. Taken together, we are using these product lines to compete ...and more »
    Read Full Article

    Login to comment.

  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Topics Mentioned